Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Neoplasms | 10 | 2021 | 163 | 3.630 |
Why?
|
| Biomarkers, Tumor | 11 | 2024 | 507 | 2.690 |
Why?
|
| Carcinoma, Renal Cell | 7 | 2021 | 105 | 2.320 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2020 | 105 | 1.890 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2019 | 44 | 0.990 |
Why?
|
| Pheochromocytoma | 2 | 2017 | 31 | 0.900 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2017 | 48 | 0.890 |
Why?
|
| Immunohistochemistry | 9 | 2021 | 897 | 0.840 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2021 | 167 | 0.750 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2020 | 11 | 0.670 |
Why?
|
| Carcinoma, Small Cell | 1 | 2020 | 22 | 0.670 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2019 | 12 | 0.620 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 40 | 0.610 |
Why?
|
| Ureteral Neoplasms | 1 | 2019 | 8 | 0.610 |
Why?
|
| Repressor Proteins | 1 | 2020 | 345 | 0.570 |
Why?
|
| Thyroid Neoplasms | 2 | 2019 | 74 | 0.570 |
Why?
|
| Cell Differentiation | 4 | 2021 | 1356 | 0.560 |
Why?
|
| Adrenocortical Carcinoma | 1 | 2017 | 2 | 0.540 |
Why?
|
| GATA3 Transcription Factor | 1 | 2017 | 17 | 0.530 |
Why?
|
| Testicular Neoplasms | 3 | 2024 | 35 | 0.530 |
Why?
|
| Middle Aged | 19 | 2024 | 17656 | 0.480 |
Why?
|
| Eye Neoplasms | 1 | 2015 | 17 | 0.460 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2015 | 13 | 0.450 |
Why?
|
| Rhabdoid Tumor | 1 | 2014 | 3 | 0.450 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 721 | 0.430 |
Why?
|
| Urothelium | 1 | 2013 | 22 | 0.420 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2013 | 10 | 0.410 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2013 | 8 | 0.410 |
Why?
|
| Wilms Tumor | 1 | 2013 | 4 | 0.410 |
Why?
|
| Prostate | 1 | 2013 | 90 | 0.400 |
Why?
|
| Adrenocortical Adenoma | 1 | 2012 | 2 | 0.390 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 5468 | 0.390 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2012 | 4 | 0.390 |
Why?
|
| Male | 19 | 2024 | 29931 | 0.380 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2013 | 84 | 0.380 |
Why?
|
| Chondroma | 1 | 2012 | 3 | 0.380 |
Why?
|
| Aged | 13 | 2024 | 14451 | 0.370 |
Why?
|
| Specimen Handling | 1 | 2012 | 61 | 0.370 |
Why?
|
| Pulmonary Embolism | 1 | 2013 | 173 | 0.350 |
Why?
|
| Melanoma | 1 | 2015 | 331 | 0.350 |
Why?
|
| Humans | 28 | 2024 | 63527 | 0.350 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2021 | 10 | 0.330 |
Why?
|
| Biopsy, Fine-Needle | 4 | 2019 | 67 | 0.330 |
Why?
|
| Neuroglia | 2 | 2021 | 79 | 0.310 |
Why?
|
| Adult | 13 | 2024 | 16895 | 0.300 |
Why?
|
| Female | 15 | 2024 | 32939 | 0.280 |
Why?
|
| Diagnosis, Differential | 5 | 2022 | 980 | 0.280 |
Why?
|
| Retrospective Studies | 7 | 2019 | 6619 | 0.260 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 685 | 0.250 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 1151 | 0.230 |
Why?
|
| Synaptophysin | 2 | 2021 | 6 | 0.210 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 197 | 0.190 |
Why?
|
| Staining and Labeling | 2 | 2020 | 126 | 0.190 |
Why?
|
| Phenytoin | 1 | 2022 | 16 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 237 | 0.180 |
Why?
|
| Drug Substitution | 1 | 2022 | 42 | 0.180 |
Why?
|
| Neuroectodermal Tumors, Primitive, Peripheral | 1 | 2021 | 1 | 0.180 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 61 | 0.170 |
Why?
|
| Gene Rearrangement | 1 | 2021 | 41 | 0.170 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 1090 | 0.170 |
Why?
|
| Seizures | 1 | 2022 | 143 | 0.170 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 311 | 0.170 |
Why?
|
| Chromogranins | 1 | 2020 | 12 | 0.170 |
Why?
|
| Meningeal Neoplasms | 1 | 2021 | 59 | 0.170 |
Why?
|
| CD56 Antigen | 1 | 2020 | 17 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 39 | 0.170 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 140 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 150 | 0.160 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2019 | 6 | 0.150 |
Why?
|
| Anoctamin-1 | 1 | 2019 | 16 | 0.150 |
Why?
|
| Phenotype | 3 | 2021 | 1208 | 0.150 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 92 | 0.150 |
Why?
|
| World Health Organization | 1 | 2018 | 34 | 0.150 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 91 | 0.150 |
Why?
|
| Thyroid Gland | 1 | 2019 | 81 | 0.140 |
Why?
|
| Urology | 1 | 2018 | 44 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 281 | 0.130 |
Why?
|
| Kidney | 1 | 2019 | 448 | 0.130 |
Why?
|
| Lung | 1 | 2022 | 957 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2018 | 378 | 0.120 |
Why?
|
| Neurons | 1 | 2021 | 923 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 719 | 0.120 |
Why?
|
| Cysts | 1 | 2015 | 41 | 0.110 |
Why?
|
| Cytodiagnosis | 1 | 2015 | 46 | 0.110 |
Why?
|
| Young Adult | 3 | 2021 | 4714 | 0.110 |
Why?
|
| Gene Dosage | 1 | 2014 | 65 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2015 | 251 | 0.110 |
Why?
|
| Age Distribution | 1 | 2015 | 257 | 0.110 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 66 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 71 | 0.110 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 52 | 0.110 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2014 | 21 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2015 | 155 | 0.100 |
Why?
|
| Cystectomy | 1 | 2013 | 35 | 0.100 |
Why?
|
| DNA Mismatch Repair | 1 | 2014 | 35 | 0.100 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2013 | 16 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 297 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 518 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2013 | 125 | 0.100 |
Why?
|
| Endometrial Neoplasms | 1 | 2014 | 61 | 0.100 |
Why?
|
| Biopsy | 3 | 2022 | 447 | 0.100 |
Why?
|
| Carcinoma | 1 | 2014 | 124 | 0.100 |
Why?
|
| Bronchoscopy | 1 | 2013 | 89 | 0.100 |
Why?
|
| Prostatectomy | 1 | 2013 | 99 | 0.100 |
Why?
|
| Glutaral | 1 | 2012 | 3 | 0.100 |
Why?
|
| Fixatives | 1 | 2012 | 16 | 0.100 |
Why?
|
| Pulmonary Artery | 1 | 2013 | 96 | 0.100 |
Why?
|
| Tissue Fixation | 1 | 2012 | 20 | 0.100 |
Why?
|
| Paraffin Embedding | 1 | 2012 | 17 | 0.100 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 22 | 0.100 |
Why?
|
| Formaldehyde | 1 | 2012 | 31 | 0.100 |
Why?
|
| Adrenalectomy | 1 | 2012 | 26 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2013 | 175 | 0.100 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 359 | 0.090 |
Why?
|
| Neurilemmoma | 1 | 2012 | 12 | 0.090 |
Why?
|
| Microscopy, Electron | 1 | 2012 | 251 | 0.090 |
Why?
|
| Norepinephrine | 1 | 2012 | 103 | 0.090 |
Why?
|
| Cross-Linking Reagents | 1 | 2012 | 117 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 491 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 527 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2015 | 847 | 0.090 |
Why?
|
| Incidence | 1 | 2015 | 1372 | 0.090 |
Why?
|
| Esophageal Neoplasms | 1 | 2012 | 86 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 769 | 0.090 |
Why?
|
| Testis | 2 | 2024 | 149 | 0.080 |
Why?
|
| Disease Progression | 1 | 2014 | 1170 | 0.080 |
Why?
|
| Child | 2 | 2021 | 4541 | 0.070 |
Why?
|
| Prognosis | 2 | 2024 | 1743 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 1234 | 0.060 |
Why?
|
| Risk Factors | 1 | 2014 | 5282 | 0.050 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2024 | 48 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2024 | 140 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2024 | 279 | 0.050 |
Why?
|
| Voltage-Gated Sodium Channel Blockers | 1 | 2022 | 4 | 0.050 |
Why?
|
| Chromogranin A | 1 | 2021 | 8 | 0.040 |
Why?
|
| SOXC Transcription Factors | 1 | 2021 | 9 | 0.040 |
Why?
|
| S100 Proteins | 1 | 2021 | 20 | 0.040 |
Why?
|
| Vincristine | 1 | 2021 | 28 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2021 | 41 | 0.040 |
Why?
|
| Dyspnea | 1 | 2022 | 124 | 0.040 |
Why?
|
| Pathologists | 1 | 2021 | 14 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2021 | 72 | 0.040 |
Why?
|
| Rituximab | 1 | 2021 | 88 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 6259 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 1641 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 285 | 0.040 |
Why?
|
| Seminiferous Tubules | 1 | 2019 | 2 | 0.040 |
Why?
|
| Spermatogonia | 1 | 2019 | 3 | 0.040 |
Why?
|
| Sertoli Cells | 1 | 2019 | 13 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2019 | 57 | 0.040 |
Why?
|
| Spermatogenesis | 1 | 2019 | 72 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 2463 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2019 | 227 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2019 | 277 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 1654 | 0.030 |
Why?
|
| CA-19-9 Antigen | 1 | 2015 | 10 | 0.030 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2015 | 33 | 0.030 |
Why?
|
| Metaplasia | 1 | 2015 | 18 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 628 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2021 | 705 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 1999 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2015 | 37 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 2184 | 0.030 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2014 | 11 | 0.030 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2014 | 9 | 0.030 |
Why?
|
| Carcinosarcoma | 1 | 2014 | 6 | 0.030 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2014 | 27 | 0.030 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2014 | 28 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 2014 | 37 | 0.030 |
Why?
|
| Cilia | 1 | 2015 | 153 | 0.030 |
Why?
|
| Mutation | 1 | 2021 | 2615 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2014 | 255 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 98 | 0.020 |
Why?
|
| Overweight | 1 | 2014 | 251 | 0.020 |
Why?
|
| Multimodal Imaging | 1 | 2012 | 69 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 931 | 0.020 |
Why?
|
| Esophagectomy | 1 | 2012 | 48 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2012 | 190 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 208 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 429 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 5627 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 868 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1405 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 778 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1185 | 0.020 |
Why?
|